Press Releases September 3, 2026 08:30 AM

Roper Technologies to present at Citi Technology Conference

Roper Technologies to present at the Citi Global TMT Conference, highlighting its market position and strategy.

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
ROP

Roper Technologies, a leading software and technology-enabled products company and a Nasdaq 100 constituent, announced it will present at the Citi Global TMT Conference on September 10, 2026. The company emphasizes its long-term cash flow growth and strategic capital deployment through acquisitions.

Roper Technologies to present at Citi Technology Conference
ROP
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Roper Technologies will present at the Citi Global TMT Conference on September 10, 2026.
  • The company is a Nasdaq 100, S&P 500, and Fortune 500 constituent with a strong track record of cash flow and shareholder value growth.
  • Roper focuses on vertical software and technology-enabled niche markets and uses capital strategically for acquisitions.

SARASOTA, Fla., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) announced that it is presenting at the Citi Global TMT Conference on Thursday, September 10, 2026, at 8:50 AM (Eastern Time). A link to the webcast presentation will be available in the “Investors” section of the Company’s website at www.ropertech.com.

About Roper Technologies

Roper Technologies is a constituent of the Nasdaq 100, S&P 500, and Fortune 500. Roper has a proven, long-term track record of compounding cash flow and shareholder value. The Company operates market leading businesses that design and develop vertical software and technology enabled products for a variety of defensible niche markets. Roper utilizes a disciplined, analytical, and process-driven approach to redeploy its excess capital toward high-quality acquisitions. Additional information about Roper is available on the Company’s website at www.ropertech.com.

Contact information:
Investor Relations
941-556-2601
[email protected]


Risks

  • Market reception to the presentation content may vary, possibly impacting investor sentiment.
  • Dependence on successful execution of acquisition strategy to maintain growth.
  • Potential sector-specific risks in vertical software and tech-enabled niche markets, including competition and technological change.

More from Press Releases

Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call Sep 6, 2026 Verizon Waives Charges for Hurricane Lowell, Prepares Network in Hawai'i Sep 5, 2026 Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen Sep 4, 2026 Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Increase in August 2026 of 0.5% Compared to 2025 Sep 4, 2026 Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference Sep 4, 2026